Impact of body mass index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: Does an obesity paradox exist?

Swiss Medical Weekly

Volumn 144, Issue , 2014, Pages

  Witassek, Fabienne ^a   Schwenkglenks, Matthias ^a   Erne, Paul ^b,c   Radovanovic, Dragana ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Klinik St Anna   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Myocardial infarction; Obesity paradox; Percutaneous coronary intervention

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SWISS; UNDERWEIGHT; BODY WEIGHT; EPIDEMIOLOGY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; SWITZERLAND; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; SWITZERLAND; THINNESS; YOUNG ADULT;

EID: 84907364084     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2014.13986     Document Type: Article

References (29)

1. Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens. 2013;7(1):85-94.
2. McAuley PA, Blair SN. Obesity paradoxes. J Sports Sci. 2011;29(8):773-82.
3. Amundson DE, Djurkovic S, Matwiyoff GN. The obesity paradox. Crit Care Clin. 2010;26(4):583-96.
4. Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J. 2007;28(14):1694-701. (Pubitemid 47227103)
5. Kadakia MB, Fox CS, Scirica BM, Murphy SA, Bonaca MP, Morrow DA. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart. 2011;97(21):1782-7.
6. Sierra-Johnson J, Wright SR, Lopez-Jimenez F, Allison TG. Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol. 2005 Jul;96(2):211-4. (Pubitemid 40978576)
7. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925-32.
8. Angeras O, Albertsson P, Karason K, Ramunddal T, Matejka G, James S, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2012 Sep 4.
9. World Health Organization. Global status report on noncommunicable diseases. Geneva, Switzerland: World Health Organization. p. v.
10. Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008;72(4):521-5. (Pubitemid 351679400)
11. Das SR, Alexander KP, Chen AY, Powell-Wiley TM, Diercks DB, Peterson ED, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011;58(25):2642-50.
12. Wienbergen H, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, et al. Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol. 2008;97(2):83-8. (Pubitemid 351257991)
13. Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short- and long-term mortality postcoronary revascularization: A meta-analysis. Obesity. 2008;16(2):442-50. (Pubitemid 351271929)
14. Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart. 2010;96(12):917-21.
15. Stauffer JC, Goy JJ, Duvoisin N, Radovanovic D, Rickli H, Erne P. Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients. Data from the Swiss registry AMIS-Plus. Swiss Med Wkly. 2012;142:w13573.
16. World Health Organization (2009) Global Database on Body Mass Index: BMI Classification. [database on the Internet] [cited 2014 Jan 20.]. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro-3.html.
17. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. (Pubitemid 39208455)
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. (Pubitemid 17055592)
19. Goldberg RJ, Cui J, Olendzki B, Spencer F, Yarzebski J, Lessard D, et al. Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction. Am Heart J. 2006;151(6):1297-304. (Pubitemid 43866613)
20. Gurm HS, Whitlow PL, Kip KE. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol. 2002;39(5):834-40. (Pubitemid 34185331)
21. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, et al. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J. 2006;151(1):168-75. (Pubitemid 41815349)
22. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666-78. (Pubitemid 44223694)
23. Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J. 2009;30(21):2584-92.
24. Hastie CE, Padmanabhan S, Slack R, Pell AC, Oldroyd KG, Flapan AD, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31(2):222-6.
25. Lazzeri C, Valente S, Chiostri M, Attana P, Picariello C, Sorini Dini C, et al. Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. Nutr Metab Cardiovasc Dis. 2013;23(3):205-11.
26. von Haehling S, Anker SD. Cachexia as major underestimated unmet medical need: Facts and numbers. Int J Cardiol. 2012;161(3):121-3.
27. Heymsfield SB. Does Body Mass Index Adequately Convey a Patient's Mortality Risk? (vol 309, pg 87, 2013). Jama - J Am Med Assoc. 2013;309(5):442-.
28. Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol. 2012;60(15):1374-80.
29. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue - an update. Horm Metab Res. 2007;39(5):314-21. (Pubitemid 46877846)